USPTO issues memorandum in response to CellzDirect and Sequenom
The USPTO tells examiners the Federal Circuit’s CellzDirect ruling “highlighted several important points” but says its subject matter eligibility guidance and training examples are already consistent with it
The USPTO has issued a memorandum in response to the Supreme Court and the Federal Circuit recently issuing rulings in subject matter eligibility cases involving life sciences method claims.
The Federal Circuit in Rapid Litigation Management v CellzDirect reversed a district...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.